Press "Enter" to skip to content

Transgene receives FDA IND Clearance for Lead myvac™ Individualized Immunotherapy, TG4050, to Commence Clinical Development in Ovarian Cancer – Yahoo Finance

admin 0

Transgene receives FDA IND Clearance for Lead myvac™ Individualized Immunotherapy, TG4050, to Commence Clinical Development in Ovarian Cancer  Yahoo Finance

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of solid tumors, today …

“liver cancer” – Google News

(Visited 3 times, 1 visits today)

Leave a Reply

Your e-mail address will not be published. Required fields are marked *